-
平臺(tái)編號(hào)：bio-50944
-
國(guó)際編號(hào)：ATCC VR-1540
-
拉丁屬名： Human respiratory syncytial virus
-
規(guī)格：frozen
-
用途：ATCC原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu) 說(shuō)明書(shū)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
中文名稱暫無(wú)
ATCC® Number:VR-1540™
Classification: Paramyxoviridae, Pneumovirus
Agent: Human respiratory syncytial virus deposited as Respiratory syncytial virus
Strain: A2
Original Source: Original isolate, deposited as VR-1302, was obtained from the lower respiratory tract of an infant with bronchiolitis and bronchopneumonia in Melbourne, Australia, 1961. VR-1540 was derived by treatment of VR-1302 to remove adenovirus contamination at ATCC.
Depositors: L Potash
Biosafety Level:2
Shipped: frozen
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Host Organism : Production Host:HEp-2 (ATCCCCL-23) Alternate Host(s): Monkey, HeLa, PrBEK, MRC-5, PrCK
Incubation : For best results, plate cells 24 to 48 hours in advance. Infect at about 80% confluence using a multiplicity of infection (MOI) of 0.1 to 1.0. Incubate 3 to 10 days at 37.0℃, until CPE are well advanced.
Effect : Yes, in vitro effects: Cytopathic effects in culture include syncytium formation by infected cells.
Store at : -70.0℃ or colder
Comments : VR-1540 was prepared from ATCCVR-1302 by growth in the presence of neutralizing serum to remove contaminating Adenovirus type 1.
